Found 0 matching trials
A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis
PHASE2The purpose of this study is the increase of resection rate of primary canc...
Location
Severance Hospital
Hyperthermia With Chemoradiotherapy in Rectal Cancer
NAThe goal of this clinical trial is to evaluate the efficacy of deep regiona...
Location
University Hospital
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
PHASE2The purpose of this study is the increase of resection rate of primary canc...
Location
Severance Hospital, Yonsei University Health System
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC
PHASE2The purpose of the study is to observe the effect of TACE/HAIC combined wit...
Location
Third Affiliated Hospital, Sun Yat-Sen University
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
PHASE2The purpose of this study is to evaluate the safety and efficacy of the com...
Location
Peking University Cancer Hospital
Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
PHASE2RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Location
Providence Cancer Center at Providence Hospital
A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer
PHASE2PRIME-RT is an open label, multi-centre phase II randomised trial with 1:1 ...
Location
Multiple Locations
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
PHASE2This is a Phase II/III randomized study involving non-metastatic rectal can...
Location
King Abdullah Medical City, Holy Capital
Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable HCC
PHASE2This study is a single-center, randomized controlled exploratory Phase II c...
Location
Shandong Cancer Hospital and Institute
Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
PHASE3Multimodality treatment that comprises preoperative fluoropyrimidine with c...
Location
The Sixth Affiliated Hospital of Sun Yat-sen University